Biotech Industry

Author : Bryan Bergeron,Paul Chan
Publisher : John Wiley & Sons
Page : 384 pages
File Size : 51,7 Mb
Release : 2004-04-12
Category : Business & Economics
ISBN : 9780471647577

Get Book

Biotech Industry by Bryan Bergeron,Paul Chan Pdf

"The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential."--John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc. "Bergeron and Chan have done a marvelous job integrating many different perspectives to give the reader a coherent road map of the biotech industry for the next decade. This powerful book is anchored by numerous relevant examples that create a framework which any life sciences professional needs to understand. Of particular note is the compelling assessment of the IT industry and its impact on the life sciences as these industries converge."--Michael A. Greeley, Managing General Partner, IDG Ventures. An in-depth examination of the growth and financing of the biotechnology industry worldwide Biotech Industry: A Global, Economic, and Financing Overview provides a thorough look at the current state of the biotechnology industry, including where major research is being conducted, where it's being applied, and where money and intellectual capital are flowing. Written by a renowned business columnist and an entrepreneurial scientist in the biotech area, this unique book gives Eos and other senior-level managers an understanding of Asia's pivotal role in the worldwide success of biotechnology commercialization, as well as insight into the biotech market over the next decade.

Author : Craig Shimasaki
Publisher : Academic Press
Page : 488 pages
File Size : 45,5 Mb
Release : 2014-04-08
Category : Medical
ISBN : 9780124047471

Get Book

Biotechnology Entrepreneurship by Craig Shimasaki Pdf

As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow. Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners. It provides a ‘how-to’ for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements. An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making. Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars Case studies are interspersed throughout each chapter to support key concepts and best practices. Enhanced by use of numerous detailed graphics, tables and flow charts

Author : Donald L. Drakeman,Lisa N. Drakeman,Nektarios Oraiopoulos
Publisher : Oxford University Press
Page : 241 pages
File Size : 54,8 Mb
Release : 2022
Category : Biotechnology industries
ISBN : 9780195084009

Get Book

From Breakthrough to Blockbuster by Donald L. Drakeman,Lisa N. Drakeman,Nektarios Oraiopoulos Pdf

"Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--

Author : Gary P. Pisano
Publisher : Harvard Business Press
Page : 278 pages
File Size : 48,6 Mb
Release : 2006
Category : Business & Economics
ISBN : 1591398401

Get Book

Science Business by Gary P. Pisano Pdf

Why has the biotechnology industry failed to perform up to expectations? This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. It also provides prescriptions for companies, seeking ways to improve the industry's performance.

Author : Donald L. Drakeman,Lisa N. Drakeman,Nektarios Oraiopoulos
Publisher : Oxford University Press
Page : 241 pages
File Size : 45,7 Mb
Release : 2022-02-14
Category : Science
ISBN : 9780197626306

Get Book

From Breakthrough to Blockbuster by Donald L. Drakeman,Lisa N. Drakeman,Nektarios Oraiopoulos Pdf

Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs. From Breakthrough to Blockbuster: The Business of Biotechnology focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.

Author : Alexandra Carina Gruber
Publisher : John Wiley & Sons
Page : 210 pages
File Size : 51,6 Mb
Release : 2008-12-17
Category : Science
ISBN : 9783527622740

Get Book

Biotech Funding Trends by Alexandra Carina Gruber Pdf

Based on interviews with successful biotech entrepreneurs and high-level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment. A must-have for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry.

Author : Vittorio Chiesa,Davide Chiaroni
Publisher : Imperial College Press
Page : 242 pages
File Size : 44,9 Mb
Release : 2005
Category : Business & Economics
ISBN : 9781860944987

Get Book

Industrial Clusters in Biotechnology by Vittorio Chiesa,Davide Chiaroni Pdf

The ultimate aim of Cleverbio has been to build a normative model that incorporates:

Author : Carole Moussalli
Publisher : Vault Inc.
Page : 184 pages
File Size : 51,9 Mb
Release : 2004
Category : Bioengineering
ISBN : 9781581312683

Get Book

Vault Career Guide to Biotech by Carole Moussalli Pdf

Vault brings its award-winning career information process to this important and booming industry, with information on career paths for both the science and business (sales, marketing, etc.) sides.

Author : Eric J. Vettel
Publisher : University of Pennsylvania Press
Page : 291 pages
File Size : 40,6 Mb
Release : 2013-03-01
Category : History
ISBN : 9780812203622

Get Book

Biotech by Eric J. Vettel Pdf

The seemingly unlimited reach of powerful biotechnologies and the attendant growth of the multibillion-dollar industry have raised difficult questions about the scientific discoveries, political assumptions, and cultural patterns that gave rise to for-profit biological research. Given such extraordinary stakes, a history of the commercial biotechnology industry must inquire far beyond the predictable attention to scientists, discovery, and corporate sales. It must pursue how something so complex as the biotechnology industry was born, poised to become both a vanguard for contemporary world capitalism and a focal point for polemic ethical debate. In Biotech, Eric J. Vettel chronicles the story behind genetic engineering, recombinant DNA, cloning, and stem-cell research. It is a story about the meteoric rise of government support for scientific research during the Cold War, about activists and student protesters in the Vietnam era pressing for a new purpose in science, about politicians creating policy that alters the course of science, and also about the release of powerful entrepreneurial energies in universities and in venture capital that few realized existed. Most of all, it is a story about people—not just biologists but also followers and opponents who knew nothing about the biological sciences yet cared deeply about how biological research was done and how the resulting knowledge was used. Vettel weaves together these stories to illustrate how the biotechnology industry was born in the San Francisco Bay area, examining the anomalies, ironies, and paradoxes that contributed to its rise. Culled from oral histories, university records, and private corporate archives, including Cetus, the world's first biotechnology company, this compelling history shows how a cultural and political revolution in the 1960s resulted in a new scientific order: the practical application of biological knowledge supported by private investors expecting profitable returns eclipsed basic research supported by government agencies.

Author : Tang Mark Chilung
Publisher : World Scientific
Page : 282 pages
File Size : 50,5 Mb
Release : 2002-12-02
Category : Business & Economics
ISBN : 9789814487641

Get Book

Essential Biotech Investment Guide, The: How To Invest In The Healthcare Biotechnology And Life Sciences Sector by Tang Mark Chilung Pdf

This invaluable book tells the reader how to invest in the healthcare biotechnology and life sciences sector, one of the fast-growing sectors of the US economy. Aimed at biotech investors as well as bioentrepreneurs and venture capitalists, it has been written from the perspectives of risk management and asset management/allocation. It strives to teach readers how to fish, rather than giving them fish. The author has over ten years of Wall Street experience in biotech research, investment banking and asset management. He holds an MBA in Finance and a PhD in Biochemistry.

Author : Toby Freedman
Publisher : CSHL Press
Page : 408 pages
File Size : 53,9 Mb
Release : 2008
Category : Biotechnology
ISBN : 9780879697259

Get Book

Career Opportunities in Biotechnology and Drug Development by Toby Freedman Pdf

An essential guide for students in the life sciences, established researchers, and career counselors, this resource features discussions of job security, future trends, and potential career paths. Even those already working in the industry will find helpful information on how to take advantage of opportunities within their own companies and elsewhere.

Author : John J. Campbell
Publisher : Pharmaceutical Press
Page : 311 pages
File Size : 45,7 Mb
Release : 2008-01-01
Category : Pharmaceutical industry
ISBN : 0976309637

Get Book

Understanding Pharma by John J. Campbell Pdf

Author : Gary Walsh
Publisher : John Wiley & Sons
Page : 499 pages
File Size : 41,6 Mb
Release : 2013-04-25
Category : Science
ISBN : 9781118685754

Get Book

Pharmaceutical Biotechnology by Gary Walsh Pdf

Pharmaceutical Biotechnology offers students taking Pharmacy and related Medical and Pharmaceutical courses a comprehensive introduction to the fast-moving area of biopharmaceuticals. With a particular focus on the subject taken from a pharmaceutical perspective, initial chapters offer a broad introduction to protein science and recombinant DNA technology- key areas that underpin the whole subject. Subsequent chapters focus upon the development, production and analysis of these substances. Finally the book moves on to explore the science, biotechnology and medical applications of specific biotech products categories. These include not only protein-based substances but also nucleic acid and cell-based products. introduces essential principles underlining modern biotechnology- recombinant DNA technology and protein science an invaluable introduction to this fast-moving subject aimed specifically at pharmacy and medical students includes specific ‘product category chapters’ focusing on the pharmaceutical, medical and therapeutic properties of numerous biopharmaceutical products. entire chapter devoted to the principles of genetic engineering and how these drugs are developed. includes numerous relevant case studies to enhance student understanding no prior knowledge of protein structure is assumed

Author : Arpita Saxena
Publisher : Springer Nature
Page : 197 pages
File Size : 49,8 Mb
Release : 2020-02-15
Category : Technology & Engineering
ISBN : 9783030361303

Get Book

Biotechnology Business - Concept to Delivery by Arpita Saxena Pdf

This book is an effort to foster the entrepreneurial spirit in young minds. It reviews a wide range of product ideas, opportunities and challenges associated with start-ups. In addition, it discusses popular molecular targets for biotechnology research / the biotech industry such as attenuated microbes, gene sequences, biomarkers, and the latest advance in the sector, CRISPR. These molecular targets can be modified for the production of sufficient quantities of food and fuel. Very often, researchers limit their focus to the proof of concept, and fail to successfully convert it into a finished product. To help young entrepreneurs avoid this pitfall, the book addresses various aspects like intellectual property regulations, commerce and management. The book’s contributing authors hail from various specialized sectors, and from around the globe. Taken together, the respective chapters are intended to overcome the borders between disciplines that otherwise rarely interact.

Author : Karl Keegan
Publisher : John Wiley & Sons
Page : 216 pages
File Size : 49,8 Mb
Release : 2009-01-15
Category : Business & Economics
ISBN : 9780470741344

Get Book

Biotechnology Valuation by Karl Keegan Pdf

The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation "Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start." —Chris Blackwell, Chief Executive, Vectura Group plc "A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians." —Steve Winokur, Managing Director, CanaccordAdams "A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value." —Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge "A fabulous approach to a difficult topic." —Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company